Lista de obras -

ABCB1 C3435T gene polymorphism as a potential biomarker of clinical outcomes in HER2-positive breast cancer patients.

artículo científico publicado en 2016

ABCB1 gene polymorphisms and response to chemotherapy in breast cancer patients: A meta-analysis

artículo científico publicado en 2017

Apoptosis and necrosis in human ejaculated spermatozoa.

artículo científico publicado en 2004

Contribution of genetic factors to platinum-based chemotherapy sensitivity and prognosis of non-small cell lung cancer

artículo científico publicado en 2016

Could 18F-FDG-PET/CT avoid unnecessary thyroidectomies in patients with cytological diagnosis of follicular neoplasm?

artículo científico publicado en 2013

Cytokine single-nucleotide polymorphisms and risk of non-small-cell lung cancer

artículo científico publicado en 2017

De novo resistance biomarkers to anti-HER2 therapies in HER2-positive breast cancer.

artículo científico

Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals

artículo científico publicado en 2019

Extrapolation of acenocoumarol pharmacogenetic algorithms.

artículo científico publicado en 2015

Gene polymorphisms as predictors of response to biological therapies in psoriasis patients

artículo científico publicado en 2016

Genetic and clinical biomarkers of tocilizumab response in patients with rheumatoid arthritis.

artículo científico publicado en 2016

Genomic approaches in the search for molecular biomarkers in chronic kidney disease

article

Impact of single nucleotide polymorphisms on the efficacy and toxicity of EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer patients

scientific article published on 09 April 2019

Information on Genetic Variants Does Not Increase Identification of Individuals at Risk of Esophageal Adenocarcinoma Compared to Clinical Risk Factors

scientific article published on 19 September 2018

Interleukins as new prognostic genetic biomarkers in non-small cell lung cancer.

artículo científico publicado en 2017

Liquid biopsy in early stage lung cancer

artículo científico publicado en 2016

MET/HGF targeted drugs as potential therapeutic strategies in non-small cell lung cancer.

artículo científico

MET: a new promising biomarker in non-small-cell lung carcinoma

artículo científico

Molecular biomarkers in colorectal carcinoma.

artículo científico

Non-HER2 signaling pathways activated in resistance to anti-HER2 therapy in breast cancer.

artículo científico

Novel BRAFI599InsMutation Identified in a Follicular Variant of a Papillary Thyroid Carcinoma: A Molecular Modeling Approach

article

PTEN and PI3K/AKT in non-small-cell lung cancer.

artículo científico publicado en 2015

Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis.

artículo científico publicado en 2012

Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients

artículo científico publicado en 2018

Pharmacogenetics role in the safety of acenocoumarol therapy.

artículo científico publicado en 2014

Prediction of stable acenocoumarol dose by a pharmacogenetic algorithm.

artículo científico publicado en 2014

Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients.

artículo científico publicado en 2012

Lista de obras de

ABCB1 C3435T gene polymorphism as a potential biomarker of clinical outcomes in HER2-positive breast cancer patients.

ABCB1 gene polymorphisms and response to chemotherapy in breast cancer patients: A meta-analysis

Apoptosis and necrosis in human ejaculated spermatozoa.

Contribution of genetic factors to platinum-based chemotherapy sensitivity and prognosis of non-small cell lung cancer

Could 18F-FDG-PET/CT avoid unnecessary thyroidectomies in patients with cytological diagnosis of follicular neoplasm?

Cytokine single-nucleotide polymorphisms and risk of non-small-cell lung cancer

De novo resistance biomarkers to anti-HER2 therapies in HER2-positive breast cancer.

Effect of CYP4F2, VKORC1, and CYP2C9 in Influencing Coumarin Dose: A Single-Patient Data Meta-Analysis in More Than 15,000 Individuals

Extrapolation of acenocoumarol pharmacogenetic algorithms.

Gene polymorphisms as predictors of response to biological therapies in psoriasis patients

Genetic and clinical biomarkers of tocilizumab response in patients with rheumatoid arthritis.

Genomic approaches in the search for molecular biomarkers in chronic kidney disease

Impact of single nucleotide polymorphisms on the efficacy and toxicity of EGFR tyrosine kinase inhibitors in advanced non-small cell lung cancer patients

Information on Genetic Variants Does Not Increase Identification of Individuals at Risk of Esophageal Adenocarcinoma Compared to Clinical Risk Factors

Interleukins as new prognostic genetic biomarkers in non-small cell lung cancer.

Liquid biopsy in early stage lung cancer

MET/HGF targeted drugs as potential therapeutic strategies in non-small cell lung cancer.

MET: a new promising biomarker in non-small-cell lung carcinoma

Molecular biomarkers in colorectal carcinoma.

Non-HER2 signaling pathways activated in resistance to anti-HER2 therapy in breast cancer.

Novel BRAFI599InsMutation Identified in a Follicular Variant of a Papillary Thyroid Carcinoma: A Molecular Modeling Approach

PTEN and PI3K/AKT in non-small-cell lung cancer.

Pharmacogenetic polymorphisms contributing to toxicity induced by methotrexate in the southern Spanish population with rheumatoid arthritis.

Pharmacogenetics of platinum-based chemotherapy: impact of DNA repair and folate metabolism gene polymorphisms on prognosis of non-small cell lung cancer patients

Pharmacogenetics role in the safety of acenocoumarol therapy.

Prediction of stable acenocoumarol dose by a pharmacogenetic algorithm.

Reduction of false-negative papillary thyroid carcinomas by the routine analysis of BRAF(T1799A) mutation on fine-needle aspiration biopsy specimens: a prospective study of 814 thyroid FNAB patients.